Alimentary Pharmacology & Therapeutics

Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma
pp. 1253-1269(17)
Authors: PETERS, C. J.; FITZGERALD, R. C.

Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome
pp. 1271-1281(11)
Authors: FRISSORA, C. L.; CASH, B. D.

Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels
pp. 1283-1292(10)
Authors: HUI, C.-K.; ZHANG, H.-Y.; SHEK, T.; YAO, H.; YUENG, Y.-H.; LEUNG, K.-W.; LAI, S.-T.; LAI, J.-Y.; LEUNG, N.; LAU, G. K.

Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C
pp. 1293-1300(8)
Authors: THURAIRAJAH, P. H.; THORBURN, D.; HUBSCHER, S.; WHITE, A.; LAI, W. K.; O'DONNELL, K.; MUTIMER, D.

Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis
pp. 1301-1309(9)
Authors: OCKENGA, J.; TIETGE, U. J. F.; BÖKER, K. H. W.; MANNS, M. P.; BRABANT, G.; BAHR, M. J.

Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis
pp. 1311-1316(6)
Authors: CALABRESE, C.; FABBRI, A.; GIONCHETTI, P.; RIZZELLO, F.; MORSELLI, C.; LIGUORI, G.; POGGIOLI, G.; CAMPIERI, M.; FEBO, G. DI

A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases
pp. 1317-1327(11)
Authors: LUDVIGSSON, J. F.; OLSSON, T.; EKBOM, A.; MONTGOMERY, S. M.

Irritable bowel syndrome: patients' attitudes, concerns and level of knowledge
pp. 1329-1341(13)
Authors: LACY, B. E.; WEISER, K.; NODDIN, L.; ROBERTSON, D. J.; CROWELL, M. D.; PARRATT-ENGSTROM, C.; GRAU, M. V.

Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study
pp. 1343-1350(8)
Authors: LEMBO, A.; ZAMAN, M.; JONES, M.; TALLEY, N. J.

Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety
pp. 1351-1361(11)
Authors: JOHANSON, J. F.; UENO, R.

Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease
pp. 1363-1364(2)
Authors: Barta, Z.; Zöld, E.; Zeher, M.

Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease: authors' reply
pp. 1364-1364(1)
Authors: Creed, T. J.; Probert, C.